Verrica Pharma Surges with Credit Facility Unlock, Fueling YCANTH & Warts Phase 3
Verrica Pharmaceuticals unlocks full credit, funding YCANTH & new skin‑cancer partnership—capital discipline meets clinical promise in a volatile biotech market.
- VERRICA PHARMACEUTICALS INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
4 minutes to read